Best Lab in Technology, Automation & Quality Excellence 2025

Best Devops Team of the Year

Patient Centricity Awards 2025: ELETS Healthcare Awards

Diagnostic App of the Year – VOH 2025

“Leading Diagnostic Chain” at the 14th Elets Healthcare Innovation Summit & Awards.

5th CX Summit & Awards 2024

3rd Annual Excellence Awards 2024

VOH Awards 2024

3rd IHW Digital Health Awards 2024

Deloitte Technology Fast 50 India 2023

Global ESG Business Award 2023

800x300-Face-Scan-With-GG-27-Jan-26_Rohit (1).webp

Redcliffe Labs introduces Face Scan, a revolutionary non-contact wellness screening solution that transforms any smartphone or camera-enabled device into a personal health check tool in just 30 seconds, offering instant insights into key wellness indicators such as heart rate, blood pressure trends, stress index, pulse, and more. While it does not replace a medical device or clinical diagnosis, Face Scan helps identify potential health indicators and guides individuals toward relevant diagnostic evaluations for deeper insights. Commenting on the launch, Aditya Kandoi, CEO, Redcliffe Labs, emphasized that making preventive health analytics accessible anytime and anywhere empowers individuals to take early, informed action and adopt healthier lives.

EH_Redcliffe.jpg

As 2025 comes to a close, Redcliffe Labs launched the ‘Before the Year Ends…’ campaign, encouraging families to reflect on their health by introducing the Annual Health Report Card, offering a comprehensive view of health trends, key vitals, yearly health summaries, and personalised recommendations, enabling early risk recognition and encouraging proactive health management. Aditya Kandoi, CEO & Founder, Redcliffe Labs, said, “Year after year, we spend our lives planning, achieving, and setting goals, yet rarely pause to truly understand our health. The Annual Health Report Card is designed to change that. It gives families clarity on where they stand today and the insight to shape a healthier tomorrow.”

Screenshot 2025-12-05 180948.png

Redcliffe Labs has identified a previously unknown USP18 gene mutation associated with a rare pediatric neurological disorder, marking the first such discovery in India and contributing new global insight into a condition recorded in only 11 cases to date. The discovery emerged from the long-term evaluation of an 11-year-old girl who had experienced fever-triggered unconsciousness, seizures, developmental delays, and progressive calcifications in the brain since infancy. Reflecting on this milestone, Aditya Kandoi, Founder and CEO of Redcliffe Labs, stated that this breakthrough goes beyond scientific recognition, demonstrating how advanced genomics combined with expert clinical interpretation can meaningfully reshape a child’s life trajectory.

1200-675-25232902-331-25232902-1760779501644 (1).jpg

Every Diwali, our homes get a fresh makeover, but one space often overlooked is the human body. Dr. Mayanka Lodha Seth, Chief Pathologist at Redcliffe Labs, explains, “Just as people deep-clean their homes before Diwali, a quick health ‘cleanse’ through preventive testing can help reset the body and detect early warning signs.” With festive indulgence in full swing, it’s important to take preventive tests such as CBC, LFT, or Lipid Profile to understand the body’s internal health and maintain balance during the celebrations.

GettyImages-666682126-1-e1587374883517.jpg

Redcliffe Labs has expanded its network in West Bengal with the launch of an advanced diagnostic lab in Midnapore, extending access to pathology services in the Tier II and Tier III regions. The lab is equipped with advanced technology to deliver accurate reports with minimal turnaround time. It offers capabilities across biochemistry, haematology, immunoassays, clinical pathology, serology, and hormones. Lab test services can be accessed by visiting lab or collection centre, with reports provided in accordance with NABL and ISO guidelines. The laboratory is strategically located to be able to extend services to surrounding areas, including Khargapur, Jhargram, Contai, Ghatal, Tamluk, and Haldia.

dsfrfrefe.png

Redcliffe Labs has renewed its association with Gautam Gambhir as its national brand ambassador for another two years. Aditya Kandoi, the Founder & CEO of Redcliffe Labs, highlighted that the partnership has grown stronger over time, built on shared values of discipline, responsibility, and a nation-first thinking. He noted that Gautam is a true reflection of the company's values, showcasing clarity, commitment, and impact—qualities that reflect the core values of Redcliffe Labs. Gautam Gambhir shared that Redcliffe Labs’ commitment to early detection and preventive testing isn’t just a service but a mindset shift towards proactive care, and he is proud to be associated with an organization that is truly changing how India thinks about healthcare.

1200-675-25232902-331-25232902-1760779501644 (2).jpg

Redcliffe operates a nationwide network of over 80 labs and has the widest home sample collection footprint in the country. The lab diagnosed over 2.5 million cases last fiscal year and continues to focus on expanding in underserved regions with a reported gross margin of 70% in FY25 and is aiming to expand it to 74% in FY26. The company plans to expand its presence to over 300 cities with 150 labs by FY28. "We are transforming lives and making diagnostics a first-line solution for millions who were previously underserved," stated Aditya Kandoi.

image (2).webp

Redcliffe Labs released a nationwide health study highlighting that Indian men show significantly higher abnormalities in key heart health markers than women. The study was based on an analysis of over 1 lakh diagnostic test records from preventive health checkups conducted over the last three years, which reveals that men exhibit 11 to 17 percent more abnormalities in indicators linked to cardiovascular disease. Aditya Kandoi, Founder & CEO, Redcliffe Labs, said, “The earlier the intervention, the higher the number can be for saving lives.”

image (1).webp

Amid the rising COVID-19 cases across India, Redcliffe Labs urges individuals to remain vigilant, consult medical professionals, and follow basic preventive measures. To support accurate and timely diagnosis, the advisory highlights the importance of molecular testing, such as RT-PCR, which detects the genetic material of the virus. Redcliffe Labs is prepared to handle increased testing demand while maintaining quality protocols and operational infrastructure to ensure timely reporting.

Screenshot 2025-07-08 113930.png

Redcliffe Labs announces Dr. Prashant Nag as its Chief Operating and Medical Officer. He comes with over two decades of experience in diagnostic operations, pathology, and clinical strategy and will oversee clinical operations, supply chain management, quality governance, regulatory compliance, and medical innovation. Aditya Kandoi, Founder and CEO, Redcliffe Labs, is pleased to welcome him and believes that his support will help strengthen infrastructure and service delivery.

Screenshot 2025-07-08 114659.png

Redcliffe Labs has diagnosed the first confirmed case of DPH2-related diphthamide syndrome-2 in India, which marks only the third such case ever reported worldwide. The diagnosis, published in the prestigious Wiley American Journal of Medical Genetics Part A, was conducted by Dr. Vykunta Raju K. N. from Indira Gandhi Hospital, Bangalore, and interpreted by Dr. Himani Pandey, Lab Head of Genomics at Redcliffe Labs, opening new avenues for early detection and genetic counseling in populations with a history of consanguinity.

Screenshot 2025-07-08 114924.png

A study by Redcliffe Labs on pregnancy risk testing called ‘penta marker screening’ revealed that it reduces false positives by 36 percent compared to existing alternatives by including three extra biomarkers: AFP, PLGF, and Inhibin-A. Aditya Kandoi, CEO and Founder, said that the findings reaffirm the potential of penta marker screening to revolutionize prenatal care, ensuring safer pregnancies while making accurate screening accessible and affordable for all.

Screenshot 2025-07-08 115048.png

A two-year study by Redcliffe Labs stated that Indian women are seeing an increase in anemia, thyroid disorders, arthritis, diabetes, and lipid imbalances. The study also found women to be three times more vulnerable than men to anemia. Regular checkups and simple lifestyle changes can help prevent long-term complications.

Screenshot 2025-07-08 120014.png

Redcliffe Labs launched a month-long campaign, “For the Women, By the Women,” that kicked off on February 8, 2025, to promote preventive healthcare through 220+ health camps across the country managed entirely by women healthcare professionals, symbolizing the strength and resilience of women in healthcare. These camps offer specially curated full-body health checkups with free hormonal health evaluations at discounted rates to cater to women across different age groups. Aditya Kandoi, CEO & Founder of Redcliffe Labs, said that preventive checkups are not just about diagnosing problems early but about empowering women to understand their bodies better and take charge of their well-being.

Screenshot 2025-07-08 120415.png

Redcliffe Labs celebrates the grand opening of its state-of-the-art diagnostic laboratory in Jamshedpur, Jharkhand. With this expansion, Redcliffe Labs has 2 Advanced Diagnostic Labs and 50+ Collection Centers in Jharkhand, marking its commitment to providing high-quality diagnostic services across Bharat. A recent healthcare study conducted by the Department of Public Health in Jharkhand underscores an alarming trend: 16.3% of the population grapples with diabetes, and over 21% are affected by hypertension. The lab's comprehensive testing capacity and ability to handle over 10,000+ samples over a month will improve the healthcare scenario for Jamshedpur and the surrounding regions.

Screenshot 2025-07-08 120654.png

A recent study done by Redcliffe Labs as a part of India’s 76th Republic Day analyzed health data from 2.8 million individuals across the country and found that one in every two individuals has lifestyle disorders. Among respondents, 52% were men, and 48% were women. The large population is grappling with chronic health conditions such as diabetes, thyroid disorders, lipid imbalances, renal disorders, fatty liver, arthritis, cardiovascular diseases, and cancer. Dr. Mayanka Lodha Seth, chief pathologist at Redcliffe Labs, highlighted that switching back to nutritious food and making a periodic health check mandatory to monitor vitals will help in early detection and informed decision-making, reversing the risk of chronic health conditions.

Screenshot 2025-07-08 120840.png

A comprehensive study conducted by Redcliffe Labs over three years with 2 million tests revealed that arthritis is no longer an ailment confined to older adults. 1 in 5 Indians are at risk of developing arthritis, underscoring the need for early diagnosis and preventive healthcare. Dr. Geetanjali Gupta, Director of Technical Operations and Quality Assurance at Redcliffe Labs, stated that identifying this condition in its early stages allows lifestyle modifications and treatments that can significantly slow progression and improve quality of life.

Screenshot 2025-07-08 121018.png

Artificial Intelligence (AI) has revolutionized the way industries function, transforming both core operations and day-to-day tasks of businesses. Aditya Kandoi, CEO and Founder of Redcliffe Labs, sees AI driving critical innovations in healthcare. For 2025, he anticipates enhancements in customization, turnaround times (TAT), and accuracy, addressing the shortage of medical professionals in India. He further adds that point-of-care testing (POCT) has enhanced accessibility for patients, regardless of geography.

WhatsApp Image 2025-07-08 at 5.45.43 PM.jpeg

Redcliffe Labs has achieved a significant breakthrough in understanding SENEBAC syndrome, which is known to disrupt normal brain development function, leading to serious symptoms like frequent seizures, developmental delays, and the gradual loss of skills in young children. The research highlights findings that emphasize the potential for targeted care approaches to protect children’s brains affected by inflammation, helping them manage symptoms and improve their quality of life. Aditya Kandoi, CEO and Founder of Redcliffe Labs said they are dedicated to expanding their expertise across all fields to provide society with the most advanced diagnostic solutions.

Screenshot 2025-07-08 121259.png

Redcliffe Labs, on the occasion of World Diabetes Day to address India’s growing diabetes epidemic, unveiled an innovative digital tool, the Prediabetes Risk Checker, on their Android app that is designed to empower individuals with good health by assessing their risk of developing diabetes. Users can gain valuable insights into their potential risk levels by answering a series of targeted questions on lifestyle habits and genetic predispositions. Post-risk evaluation, the tool provides tailored recommendations, including lifestyle changes and diagnostic testing for timely medical intervention. This initiative reaffirms the company’s commitment to making preventive healthcare actionable, driving awareness, and fostering healthier communities.

Screenshot 2025-07-08 121417.png

Redcliffe Labs has expanded its footprint in Gujarat with two more state-of-the-art diagnostic laboratories in Surat and Vadodara, intending to make accurate and reliable diagnostics accessible in Tier II and Tier III cities. The company now operates with a network of 3 laboratories and 30 collection centers across the state, enabling accurate reports within the minimum possible turnaround time. The lab maintains exceptional quality standards by following NABL and ISO protocols, utilizing six-sigma methodologies, and performing more than 50 regular stringent quality checks across its diagnostic network.

Screenshot 2025-07-08 121526.png

Redcliffe Labs has invested in Celara Diagnostics, a leading diagnostic chain based in Bengaluru. This significant expansion will broaden the range of diagnostic services available to patients in Karnataka, offering high-quality radiology and specialized pathology with improved turnaround times and an enhanced customer experience. The lab owns and operates more than 80 labs, processing tests from over 2000 collection centers and home sample collection, being supported by over 1000 phlebotomists across 220 cities in India.

Screenshot 2025-07-08 121700.png

Redcliffe Labs has raised $42 million in Series C funding to open more labs and collection centers, along with expanding the home collection network. Acquisitions have been made by the company in north-western India, and pursuits for pan-India expansion through strategic partnerships and further acquisitions are in the pipeline. Mr. Aditya Kandoi, founder and CEO, Redcliffe Labs, says that their aim is to democratize access to high-quality, affordable, and accurate diagnostics for every Indian, with a particular focus on the underserved populations in Tier-II and Tier-III cities.

Screenshot 2025-07-08 121847.png

Redcliffe Labs announced the launch of advanced Mpox testing capabilities, assuring key health authorities, including Noida’s Chief Medical Officer (CMO) and the Indian Council of Medical Research (ICMR), of its readiness to manage the Mpox situation. Aditya Kandoi, CEO, Redcliffe Labs, said that they are ready to work with health authorities to ensure the safety and well-being of the community. This highly contagious viral infection demands early detection and effective intervention to limit its spread and safeguard public health.

WhatsApp Image 2025-07-08 at 5.47.30 PM.jpeg

Redcliffe Labs launched two diagnostic laboratories in Faridabad and Rohini to meet the rising demand for quality diagnostics, ensuring that they are well-equipped to offer over 3,600 routine and specialized tests with advanced pathology testing capabilities including biochemistry, hematology, immunoassays, histopathology, clinical pathology, cytopathology, genomic testing, hormones, microbiology, and infectious disease serology. Following six-sigma processes and 50+ stringent quality checks in pre-analytical, analytical, and post-analytical phases, 100% report correctness is guaranteed.

Awards & Recognition